LCN2 and acute kidney injury: Following its promising debut as an early biomarker for AKI after cardiac surgery [7] NGAL was frequently used to asses kidney damage in human subjects after kidney transplantation, contrast agent administration, or in the critically ill patients [4, 8, 9], and in mouse AKI models [4, 10, 11].